ClinicalTrials.Veeva

Menu

Functional Diagnostic Accuracy of Ultrasonic Flow Ratio in Assessment of Left Main Coronary Artery Stenosis (FUNCTION II)

N

National Center for Cardiovascular Diseases

Status

Enrolling

Conditions

Left Main Coronary Artery Disease

Treatments

Diagnostic Test: fractional flow reserve (FFR); ultrasonic flow ratio (UFR); intravascular ultrasound (IVUS)

Study type

Observational

Funder types

Other

Identifiers

NCT06053944
2022-12M-C&T-B-043

Details and patient eligibility

About

This is a prospective, observational, single-center study. The main purpose of this study is to evaluate the diagnostic accuracy of offline computational ultrasonic flow ratio (UFR) in predicting functionally significant left main (LM) coronary stenosis with conventional pressure wire-based fractional flow reserve (FFR) as the standard reference. The study will be conducted in Fuwai Hospital, and a total of 120 patients with intermediated left main coronary vessel diameter stenosis ≥30% and ≤80% are planned to be recruited. Participants who meet the inclusion criteria and do not meet the exclusion criteria will undergo intravascular ultrasound (IVUS) followed by FFR examination. IVUS imaging will be sent to an independent core laboratory for UFR calculation. UFR analyses were performed offline in a blinded fashion without awareness of FFR measurement. Using FFR≤0.80 as the gold standard, the sensitivity and specificity of UFR in the functional significance of left main coronary artery stenosis will be analyzed.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stable angina pectoris, unstable angina pectoris, or after the acute phase of myocardial infarction
  • Age ≥18 years
  • Written informed consent
  • Intermediated left main coronary lesions (diameter stenosis of 30%-80% by visual estimation from coronary angiography)

Exclusion criteria

  • Ineligible for diagnostic IVUS or FFR examination
  • Prior coronary artery bypass grafting of the interrogated vessels
  • Myocardial infarction within 72 h of coronary angiography
  • Severe heart failure
  • Serum creatinine levels >150 umol/L, or glomerular filtration rates <45 ml/ kg/1.73 m2
  • Allergy to the contrast agent or adenosine
  • Life expectancy < 2 years
  • Proximal LAD diffuse lesions (diameter stenosis > 50%)
  • IVUS pullback not covering the entire lesion
  • Severe myocardial bridge in the interrogated vessel

Trial contacts and locations

1

Loading...

Central trial contact

Jie Qian, MD; Cheng Yang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems